Peptostreptococcus as a potential biomarker and therapeutic target in colorectal cancer
The oral bacterium Peptostreptococcus may influence colorectal cancer progression and serves as a potential biomarker.
Asset / Drug
Drug and asset intelligence for Peptostreptococcus with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.